| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |